ArticleScientific reports2022
Emotional profiling and cognitive networks unravel how mainstream and alternative press framed AstraZeneca, Pfizer and COVID-19 vaccination campaigns.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 31 citations in OpenAlex.
- Evaluating the quality and reliability of cervical cancer related videos on YouTube, Bilibili, and Tiktok: a cross-sectional analysis.BMC public health · 2025Article
- Cognitive modelling of concepts in the mental lexicon with multilayer networks: Insights, advancements, and future challenges.Psychonomic bulletin & review · 2024Review
- How ready is speech-to-text for psychological language research? Evaluating the validity of AI-generated English transcripts for analyzing free-spoken responses in younger and older adults.Behavior research methods · 2024Article
- Negative online news articles are shared more to social media.Scientific reports · 2024Article
- Year 2022 in Medical Natural Language Processing: Availability of Language Models as a Step in the Democratization of NLP in the Biomedical Area.Yearbook of medical informatics · 2023Article
- Article
- Cognitive Networks for Knowledge Modeling: A Gentle Introduction for Data- and Cognitive Scientists.Wiley interdisciplinary reviews. Cognitive scienceReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 vaccines have been largely debated by the press. To understand how mainstream and alternative media debated vaccines, we introduce a paradigm reconstructing time-evolving narrative frames via cognitive networks and natural language processing. We study Italian news articles massively re-shared on Facebook/Twitter (up to 5 million times), covering 5745 vaccine-related news from 17 news outlets over 8 months. We find consistently high trust/anticipation and low disgust in the way mainstream sources framed "vaccine/vaccino". These emotions were crucially missing in alternative outlets. News titles from alternative sources framed "AstraZeneca" with sadness, absent in mainstream titles. Initially, mainstream news linked mostly "Pfizer" with side effects (e.g. "allergy", "reaction", "fever"). With the temporary suspension of "AstraZeneca", negative associations shifted: Mainstream titles prominently linked "AstraZeneca" with side effects, while "Pfizer" underwent a positive valence shift, linked to its higher efficacy. Simultaneously, thrombosis and fearful conceptual associations entered the frame of vaccines, while death changed context, i.e. rather than hopefully preventing deaths, vaccines could be reported as potential causes of death, increasing fear. Our findings expose crucial aspects of the emotional narratives around COVID-19 vaccines adopted by the press, highlighting the need to understand how alternative and mainstream media report vaccination news.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.